Testing a medication to reduce alcohol use in people with HIV

This is a pilot study testing whether semaglutide, combined with personalized counseling from a clinical pharmacist, can help people with HIV reduce their alcohol use over 12 weeks. The study is small — only 30 people will participate — to see if this approach is safe, acceptable to patients, and shows promise before testing it in a larger group. You would receive the medication along with regular counseling sessions focused on helping you change your drinking habits.

Many people with HIV also struggle with alcohol use disorder, which can make HIV treatment harder and cause other health problems. This medication has shown promise in other settings, and researchers want to see if it could be a helpful, safe option specifically for people living with HIV who want to reduce their drinking.